← Back to all trials
Recruiting
NCT05714124
Liver Embolization Approaches for Tumor Management
Conditions: Hepatocellular Carcinoma, Cholangiocarcinoma, Metastatic Colon Cancer, Metastatic Cancer, Metastatic Gastric Cancer, Primary Liver Cancer, Metastatic Pancreatic Cancer
Sex: All
Ages: 18 Years – N/A
Enrollment: 580
Sponsor: IRCCS San Raffaele
Location: Italy
Summary
The goal of this evaluate short, medium and long term outcome of the different embolization techniques in patients with primary and secondary hepatic tumors.
The main aim is to evaluate progression free survival following embolization in this study population or evaluate residual hepatic volume in cases in which these techniques are used to induce liver regeneration.
This study is an observational registry - all patients will follow their normal therapeutic and treatment scheme as per clinical practice, without any additional intervention.
Eligibility Criteria
Inclusion Criteria:≥ 18 yoapatients with patients with primary or secondary liver disease not amenable for surgery or ablationpatients with primary or secondary liver tumors candidates for major surgery prior to induction of hypertrophyable and willing to sign informed consentExclusion Criteria:pregnant womenpatients with uncorrectable coagulopathydiffuse extrahepatic diseasefor lobar TACE and TARE - presence of bilodigestive shuntfor TARE - >20% hepatopulmonary shunt
Source: ClinicalTrials.gov (NCT05714124). StuddyBuddy aggregates publicly available trial information.